Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor
3 clinical trials · Condition
◉ Watch Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor
| Record | Firm | Date |
|---|---|---|
| Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors (NCT00301756) | National Cancer Institute (NCI) | 2006-09-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442) | Gynecologic Oncology Group | 1992-06-01 |
Track Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor automatically
Every clearance here is in the API, with alerts when new ones post.